Daré Bioscience
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $-21 | $25 | $-63 | $41 |
Gross Profit | -21 | 25 | -14,286 | 31 |
EBITDA | -3,367 | -4,423 | -5,382 | -4,672 |
EBIT | -3,827 | -4,581 | -5,388 | -4,681 |
Net Income | -4,016 | -4,378 | -5,506 | -4,703 |
Net Change In Cash | -21 | 25 | -63 | 41 |
Free Cash Flow | -5,264 | -5,627 | 4,663 | -5,641 |
Cash | 5,035 | 10,329 | 15,698 | 11,232 |
Basic Shares | 8,871 | 8,759 | 8,497 | 8,534 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $9 | $2,808 | $10,000 | $10,000 |
Gross Profit | -503 | 2,770 | 10,000 | -26 |
EBITDA | -23,409 | -30,902 | -31,361 | -39,042 |
EBIT | -23,451 | -30,940 | -31,385 | -39,068 |
Net Income | -4,054 | -30,161 | 406,802 | -38,326 |
Net Change In Cash | 9 | 2,808 | 10,000 | 10,000 |
Free Cash Flow | 4,821 | -39,486 | -18,151 | -28,778 |
Cash | 15,698 | 10,476 | 34,669 | 51,674 |
Basic Shares | 8,497 | 7,275 | 7,048 | 5,096 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.45 |
2025-03-31 | -$0.50 |
2024-12-31 | -$0.65 |
2024-09-30 | -$0.55 |
